FDA Clears Wearable Platform for Parkinson’s Symptom Monitoring
The system uses clinical-grade wearables and algorithms to provide objective data on tremors, sleep, and medication compliance.
The system uses clinical-grade wearables and algorithms to provide objective data on tremors, sleep, and medication compliance.
The FDA has cleared Dexcom's next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes.
The new RhythmStar with built-in 4G cellular connectivity conducts extended remote monitoring without an additional communication device.
The system uses clinical-grade wearables and algorithms to provide objective data on tremors, sleep, and medication compliance.